首页> 外国专利> RECOMBINANT PLASMID DNA p280_2GM CODING POLYPEPTIDE WITH PROPERTIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OF HUMAN, STRAIN ESCHERICHIA COLI SG 20050/p280_2GM - PRODUCER OF POLYPEPTIDE WITH PROPERTIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OF HUMAN AND METHOD OF OBTAINING OF SAID POLYPEPTIDE

RECOMBINANT PLASMID DNA p280_2GM CODING POLYPEPTIDE WITH PROPERTIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OF HUMAN, STRAIN ESCHERICHIA COLI SG 20050/p280_2GM - PRODUCER OF POLYPEPTIDE WITH PROPERTIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OF HUMAN AND METHOD OF OBTAINING OF SAID POLYPEPTIDE

机译:具有人类粒应变巨噬细胞集落刺激因子特性的重组质粒p280_2GM编码多肽,大肠杆菌,粒状巨噬细胞集聚体,具有粒细胞-巨噬细胞集落形成特性的多肽的生产者

摘要

FIELD: biotechnology.;SUBSTANCE: invention relates to biotechnology, particularly to genetic engineering, and is an in vitro constructed recombinant plasmid DNA containing two copies of a human granulocyte-macrophage colony-stimulating factor (GM-CSF) synthetic gene, Escherichia coli strain SG20050/p280_2GM is a producer of said polypeptide and a method of producing a polypeptide with GM-CSF properties. Recombinant plasmid DNA p280_2GM codes a polypeptide with properties of granulocyte-macrophage colony-stimulating factor (GM-CSF) of a person characterized by the following features: codes the amino acid sequence of the mature human GM-CSF; has molecular weight of 2.95 MDa (4,422 base pairs); consists of: PsTI/BamHI(pol)-fragment of plasmid DNA p280GM (1,484 base pairs) containing C-terminal part of beta-lactamase gene, tandem of promoters of tryptophan operon E. coli and synthetic gene GM-CSF of human, as well as EcoRI(pol)/PstI (2,938 base pairs) – a fragment of the same plasmid containing the synthetic human GM-CSF gene and the N-terminal portion of the beta-lactamase gene; contains: – tandem promoters of tryptophan operon E. coli; two copies of human synthetic GM-CSF gene; transcription terminator t0 of lambda phage; as a genetic marker, a beta-lactamase gene determining the resistance of E. coli transformed plasmid p280_2GM to ampicillin antibiotics; unique recognition sites by restriction endonucleases located at the following distances to the right from EcoRI site (279 base pairs) – BamHI – 912 nucleotides; PstI – 3,396 nucleotides.;EFFECT: invention increases output of polypeptide with properties of granulocyte-macrophage colony-stimulating factor.;3 cl, 8 dwg, 4 tbl, 15 ex
机译:技术领域本发明涉及生物技术,尤其涉及基因工程,并且是体外构建的重组质粒DNA,其包含两个拷贝的人类粒细胞-巨噬细胞集落刺激因子(GM-CSF)合成基因大肠杆菌菌株。 SG20050 / p280_2GM是所述多肽的生产者以及生产具有GM-CSF特性的多肽的方法。重组质粒DNA p280_2GM编码具有人粒细胞-巨噬细胞集落刺激因子(GM-CSF)特性的多肽,其特征在于:编码成熟人GM-CSF的氨基酸序列。分子量为2.95 MDa(4,422个碱基对);由以下组成:质粒DNA p280GM的PsTI / BamHI(pol)片段(1,484个碱基对),其中包含β-内酰胺酶基因的C末端部分,色氨酸操纵子大肠杆菌的启动子和人的合成基因GM-CSF以及EcoRI(pol)/ PstI(2,938个碱基对)–包含合成的人GM-CSF基因和β-内酰胺酶基因N端部分的同一质粒的片段;包含:–色氨酸操纵子大肠杆菌的串联启动子;人类合成的GM-CSF基因的两个副本; λ噬菌体的转录终止子t0;作为遗传标记,β-内酰胺酶基因决定了大肠杆菌转化的质粒p280_2GM对氨苄西林抗生素的耐药性;限制性内切核酸酶的唯一识别位点位于距EcoRI位点右端以下距离处(279个碱基对)– BamHI – 912个核苷酸; PstI – 3,396个核苷酸。;效果:发明增加了具有粒细胞-巨噬细胞集落刺激因子特性的多肽产量。3cl,8 dwg,4 tbl,15 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号